UPDATE Targacept loses big shareholder, finds error in previous study – Winston-Salem Journal (blog)

UPDATE Targacept loses big shareholder, finds error in previous study
Winston-Salem Journal (blog)
Targacept Inc.'s rollercoaster ride – financially and in research – dropped again today with the news that a recent asthma study did not perform as first stated on March 27. The company, based in Winston-Salem, also learned in a regulatory filing

and more »

View full post on asthma – Google News

Targacept loses big shareholder, finds error in previous study – Winston-Salem Journal

Targacept loses big shareholder, finds error in previous study
Winston-Salem Journal
Targacept Inc.'s rollercoaster ride – financially and in research – dropped again today with the news that a recent asthma study did not perform as first stated on March 27. The company, based in Winston-Salem, also learned in a regulatory filing

and more »

View full post on asthma – Google News

Targacept reports error in asthma study – Triad Business Journal

Targacept reports error in asthma study
Triad Business Journal
Targacept disclosed an error in the analysis of a potential asthma treatment, but says the candidate still holds promise. Targacept said an error in the analysis of a drug it recently studied as a potential treatment for asthma affected the results,
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of MarketWatch (press release)
Targacept Revises Results Of Exploratory Drug Study; Shares SlumpWall Street Journal
Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987NASDAQ
Benzinga
all 11 news articles »

View full post on asthma – Google News